Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyril Empig

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Vaccine|October 21, 2006
LC16m8: an attenuated smallpox vaccineJulie Kenner, Fiona Cameron, Cyril Empig, et al.
Journal of Virology|May 14, 2004
Complementation of a binding-defective retrovirus by a host cell receptor mutantZhaohui Qian, Hongzhe Wang, Cyril Empig, et al.
Plos One|March 20, 2012
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradicationEkaterina Dadachova, Scott G Kitchen, Gregory Bristol, et al.
Antiviral Research|November 21, 2012
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibodyStuart Dowall, Irene Taylor, Paul Yeates, et al.
The Journal of Infectious Diseases|September 17, 2011
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adultsJeffrey S Kennedy, Marc Gurwith, Cornelia L Dekker, et al.
Genome Biology|November 23, 2014
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityStuart D Dowall, David A Matthews, Isabel Garcia-Dorival, et al.
Molecular Cancer Research : MCR|February 11, 2017
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 ExpressionCanan Kasikara, Sushil Kumar, Stanley Kimani, et al.
Vaccine|January 25, 2006
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeCyril Empig, Julie R Kenner, Marcel Perret-Gentil, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccine|October 21, 2006
LC16m8: an attenuated smallpox vaccineJulie Kenner, Fiona Cameron, Cyril Empig, et al.
Journal of Virology|May 14, 2004
Complementation of a binding-defective retrovirus by a host cell receptor mutantZhaohui Qian, Hongzhe Wang, Cyril Empig, et al.
Plos One|March 20, 2012
Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradicationEkaterina Dadachova, Scott G Kitchen, Gregory Bristol, et al.
Antiviral Research|November 21, 2012
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibodyStuart Dowall, Irene Taylor, Paul Yeates, et al.
The Journal of Infectious Diseases|September 17, 2011
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adultsJeffrey S Kennedy, Marc Gurwith, Cornelia L Dekker, et al.
Genome Biology|November 23, 2014
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicityStuart D Dowall, David A Matthews, Isabel Garcia-Dorival, et al.
Molecular Cancer Research : MCR|February 11, 2017
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 ExpressionCanan Kasikara, Sushil Kumar, Stanley Kimani, et al.
Vaccine|January 25, 2006
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeCyril Empig, Julie R Kenner, Marcel Perret-Gentil, et al.
Pageof 1